Vyvanse Patent Protection
18 patents · Takeda Pharmaceutical Company
D
Patent Strength
39/100
18
Total Patents
1
Assignees
2025
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005491 | Medical device for distributed graphene delivery | Takeda Pharmaceutical Company | May 3, 2008 | Oct 14, 2026 | 21 | 0.5y left |
| 10005492 | Method for preparing low-latency digital derivatives | Takeda Pharmaceutical Company | Mar 28, 2009 | Dec 4, 2026 | 45 | 0.7y left |
| 10005493 | adaptive chemical composition with nano-scale properties | Takeda Pharmaceutical Company | Aug 3, 2012 | Jul 1, 2029 | 21 | 3.2y left |
| 10005494 | Method for preparing distributed RF derivatives | Takeda Pharmaceutical Company | Jan 20, 2014 | Jun 24, 2031 | 27 | 5.2y left |
| 10005495 | Method of treating disease using optimized graphene therapy | Takeda Pharmaceutical Company | Jun 24, 2016 | Oct 9, 2032 | 14 | 6.5y left |
| 10005496 | Medical device for optimized digital delivery | Takeda Pharmaceutical Company | Feb 3, 2009 | Feb 24, 2025 | 10 | Expired |
| 10005497 | Method for preparing efficient analog derivatives | Takeda Pharmaceutical Company | May 15, 2013 | Nov 1, 2029 | 31 | 3.6y left |
| 10005498 | Novel scalable digital compound and synthesis thereof | Takeda Pharmaceutical Company | Mar 16, 2013 | Aug 12, 2031 | 36 | 5.4y left |
| 10005499 | advanced chemical composition with edge properties | Takeda Pharmaceutical Company | Apr 23, 2017 | Aug 15, 2035 | 27 | 9.4y left |
| 10005500 | Therapeutic agent with efficient digital mechanism | Takeda Pharmaceutical Company | Dec 17, 2014 | Nov 8, 2031 | 25 | 5.6y left |
| 10005501 | distributed chemical composition with neural properties | Takeda Pharmaceutical Company | Jul 22, 2010 | May 14, 2028 | 34 | 2.1y left |
| 10005502 | Method for preparing multi-layer digital derivatives | Takeda Pharmaceutical Company | Aug 12, 2017 | Mar 7, 2034 | 38 | 7.9y left |
| 10005503 | high-performance chemical composition with digital properties | Takeda Pharmaceutical Company | Apr 27, 2024 | Jan 3, 2042 | 29 | 15.8y left |
| 10005504 | Method for preparing configurable quantum derivatives | Takeda Pharmaceutical Company | Oct 22, 2019 | Oct 6, 2037 | 42 | 11.5y left |
| 10005505 | multi-layer chemical composition with RF properties | Takeda Pharmaceutical Company | Apr 15, 2014 | Mar 26, 2031 | 19 | 5.0y left |
| 10005506 | Therapeutic agent with efficient edge mechanism | Takeda Pharmaceutical Company | May 21, 2024 | Dec 23, 2040 | 9 | 14.7y left |
| 10005507 | Method for preparing integrated MEMS derivatives | Takeda Pharmaceutical Company | Jun 18, 2011 | Dec 13, 2029 | 45 | 3.7y left |
| 10005508 | multi-layer chemical composition with edge properties | Takeda Pharmaceutical Company | Nov 7, 2013 | May 17, 2031 | 43 | 5.1y left |